glp-1 employer healthcare costs A Cost That's Hard to (G)u(LP-1) Down 2026 Employer Health Care Strategy

Description

Federal courts and the FDA quickly began to side with the manufacturers, issuing warnings and injunctions that forced many of these back-alley productions to stop

GLP1 medications slow gastric emptying, and some experts have raised questions around oral medication absorption, including oral HRT

Many people prefer to take their medications orally to avoid the inconvenience, pain, and discomfort associated with injections

Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively